FindTrial
Sign In

â??AN OBSERVATIONAL STUDY OF HIGH FLOW NASAL OXYGEN THERAPY IN COVID 19 PATIENTS ADMITTED IN INTENSIVE CARE UNITâ??

An observational study of High Flow Nasal Oxygen Therapy in COVID-19 patients admitted in intensive care unit

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029563
Enrollment
100
Registered
2020-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between age 18-60years 2.Both males and females 3.Patients with type 1 respiratory failure 4.Patients with SpO2 less than or equal to 92% on room air 5.Patients with or without co morbidities

Exclusion criteria

Exclusion criteria: 1.Patientâ??s refusal for HFNO 2.Patients below 18years and above 60years 3. Patients with tracheostomy 4. Patients with Claustrophobia 5.Patients with urgent need for endotracheal intubation 6.Patients with GCS less than 8 or raised intracranial tension 7.Patients with upper airway obstruction 8. Pregnant patients

Design outcomes

Primary

MeasureTime frame
Whether high flow nasal oxygen therapy can treat hypoxia in COVID 19 patientsTimepoint: During ICU stay—

Secondary

MeasureTime frame
1.To analise failure rate of high flow nasal oxygen therapy in COVID 19 patients and escalation to invasive and non-invasive ventilation.Timepoint: during ICU stay—

Countries

India

Contacts

Public ContactDr Ashwin sonkamble

Grant government medical college

seeashwin@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026